Carregant...
Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA
Upon the discovery of RNA interference (RNAi), canonical small interfering RNA (siRNA) has been recognized to trigger sequence-specific gene silencing. Despite the benefits of siRNAs as potential new drugs, there are obstacles still to be overcome, including off-target effects and immune stimulation...
Guardat en:
| Publicat a: | Asian J Pharm Sci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Shenyang Pharmaceutical University
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032099/ https://ncbi.nlm.nih.gov/pubmed/32104477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2018.12.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|